NCT02551731View on ClinicalTrials.gov

Cannabidiol Oral Solution for Treatment of Refractory Infantile Spasms

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 27, 2016

Primary Completion Date

September 6, 2016

Study Completion Date

September 6, 2016

Conditions
Spasms, Infantile
Interventions
DRUG

Cannabidiol Oral Solution

20 or 40 mg/kg/day BID

Trial Locations (4)

33155

Miami Children's Hospital, Miami

48073

Beaumont Health System, Royal Oak

90095

Mattel Children's Hospital at UCLA, Los Angeles

94143

University of California - San Francisco, San Francisco

Sponsors
All Listed Sponsors
lead

INSYS Therapeutics Inc

INDUSTRY